Dr. Nandini Tandon, Co-Founder, IndUS Setu Global, is a venture capitalist for past 17 years in Silicon Valley in emerging and critical technologies.

Nandini brings deep domain expertise to her investments, that she gained from her experience working with global leaders at diverse cutting-edge tech and innovation driven institutions, in myriad industries, Pharma, biotech, Medtech, Semiconductor at Glaxo Wellcome, Chiron, Zyomyx, Microelectronic Center of North Carolina respectively.

As a venture capitalist Nandini made 12 investments in life saving breakthrough technologies with 11 exits, 9 being acquired by market leaders such as Pfizer, Gilead, Amgen, General Electric and 2 companies following IPO route.

Dr. Tandon was Managing Director, Lumira-MDS Capital in Palo Alto with 1.2 billion USD under management and before was Partner, RBC Capital Partners, in San Francisco, and was responsible for opening and establishing both the offices.

Nandini has been on multiple global, private, public, for profit and not for profit boards, across US, UK, Netherlands, UAE, and India. Presently, she is advisor to Stanford University’s Byers Center for Biodesign’s India program, is on the board of Bay Area Economic Council Institute, the premiere US economic think tank, is on the board of MCI Inc., an AI to EQ company, is Board Member of QB3, Quantitative Biology, (UCSF, UC Berkeley, UC Santa Cruz), is on Board of Advisors to Maker Bhavan Foundation and is on the Leadership Council of Indian Institute of Technology Gandhinagar, IIT GN.

A White House Intern, Nandini received Ph.D. in biochemistry, Phi Lambda Upsilon from Duke University, North Carolina and B.A. cum laude, Phi Beta Kappa from Hollins University, Virginia. She holds a global patent in semiconductor from Microelectronic Center of North Carolina, RTP, NC. Dr. Tandon is married and lives in Silicon Valley-Bay area, California with her husband and their son.